enkephalinamide-met, ala(2)- has been researched along with hexamethonium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koelbel, CB; Leduc, L; Mayer, EA; Snape, WJ; Vandeventer, G | 1 |
| Severson, K; Tackett, RL | 1 |
2 other study(ies) available for enkephalinamide-met, ala(2)- and hexamethonium
| Article | Year |
|---|---|
Neurokinin inhibition of cholinergic myenteric neurons in canine antrum.
Topics: Acetylcholine; Animals; Atropine; Dinoprostone; Dogs; Electric Stimulation; Enkephalin, Methionine; Female; Hexamethonium; Hexamethonium Compounds; In Vitro Techniques; Indomethacin; Male; Muscle, Smooth; Myenteric Plexus; Naloxone; Neurokinin A; Neurons; Nifedipine; Phentolamine; Propranolol; Pyloric Antrum; Substance P; Tetrodotoxin; Vasoactive Intestinal Peptide | 1990 |
Enhanced hemodynamic response to [D-ALA2,D-MET5]-methionine enkephalin (DAME) in streptozotocin-induced diabetic rats is reversed by insulin replacement.
Topics: Animals; Blood Flow Velocity; Blood Glucose; Blood Pressure; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Enkephalin, Methionine; Ganglionic Blockers; Hexamethonium; Hindlimb; Insulin; Male; Naloxone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Vascular Resistance | 1998 |